asdf098

$BMY bouncing off long-term support (4/5)

Long
NYSE:BMY   Bristol-Myers Squibb Company
Conviction: 4/5
might be better to buy when the stock goes over 1998 resistance


General Thesis
  • bouncing off of multi-cycle support (since 1974)
  • Weekly RSI showing sliiight bullish divergence

Growth
  • Margins quite low compared to own history
  • low growth

Value
  • very cheap
    Fundamentals
    low debt/asset ratio and plenty of cash to deal with short term debts

    Potential Risks
  • expensive market...
  • long-term resistance around 76 since 1998

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.